VanEck Biotech ETF
BBH
BBH
83 hedge funds and large institutions have $294M invested in VanEck Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 26
51% less call options, than puts
Call options by funds: $2.87M | Put options by funds: $5.85M
Holders
83
Holding in Top 10
–
Calls
$2.87M
Puts
$5.85M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$5.45M | |
| 3 | +$4.18M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.04M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.23M |
Top Sellers
| 1 | -$6.44M | |
| 2 | -$6.28M | |
| 3 | -$4.16M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.7M |
| 5 |
Morgan Stanley
New York
|
-$3.09M |